Medical College of Wisconsin
Stroke survivors have compromised vascular function which may contribute to secondary stroke risk, cardiovascular disease, and may limit their exercise tolerance. Preliminary data shows an antioxidant supplement called MitoQ may improve vascular function and muscle activity in individuals post-stroke.
Inclusion Criteria: * Age 18-85 years * Cortical or subcortical stroke ≥ 6 months ago * Follows 2-step command * English speaking Exclusion Criteria: * Unable to walk 10 meters without physical assistance (able to use assistive device) * Unable to perform HIIE * Head Trauma \< 6 months ago * Resting BP ≥ 180/100 mmHg * Heart attack \<1 year ago. * Pregnant and/or breastfeeding * History of other neurological disease * Unable to obtain MCAv signal * Other significant medical condition likely to influence study or jeopardize safety as assessed by Primary Investigator
MitoQ is an over the counter supplement that increases delivery to the mitochondria. Similar to studies performed in middle age/older adults and individuals with peripheral arterial disease, we will administer 1 single oral dose of 80mg of MitoQ or a placebo pill. We will examine the acute effects at the baseline vascular visit as well as chronically after 4 weeks of MitoQ supplementation at home.
Placebo
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.